ARTICLE | Company News
Karo Bio, Wyeth deal
April 24, 2006 7:00 AM UTC
KARO said it will receive an undisclosed milestone payment from WYE under their 2001 deal to develop atherosclerosis therapeutics that target the liver X receptor (LXR). The payment was triggered by ...